SMMT - Summit Therapeutics plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 524.29M
Enterprise Value 3-470.18k
Trailing P/E 0.70
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.27
Price/Book (mrq)0.51
Enterprise Value/Revenue 3-0.00
Enterprise Value/EBITDA 6-0.02

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Jan 31, 2018
Most Recent Quarter (mrq)Jul 31, 2018

Profitability

Profit Margin 31.85%
Operating Margin (ttm)26.54%

Management Effectiveness

Return on Assets (ttm)25.73%
Return on Equity (ttm)118.87%

Income Statement

Revenue (ttm)90.16M
Revenue Per Share (ttm)6.08
Quarterly Revenue Growth (yoy)744.50%
Gross Profit (ttm)27.24M
EBITDA 24.83M
Net Income Avi to Common (ttm)28.72M
Diluted EPS (ttm)1.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22.64M
Total Cash Per Share (mrq)1.38
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.65
Book Value Per Share (mrq)2.66

Cash Flow Statement

Operating Cash Flow (ttm)-45.26M
Levered Free Cash Flow (ttm)6.13M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.37
52-Week Change 3-88.13%
S&P500 52-Week Change 35.73%
52 Week High 315.90
52 Week Low 31.35
50-Day Moving Average 31.79
200-Day Moving Average 35.18

Share Statistics

Avg Vol (3 month) 351.4k
Avg Vol (10 day) 320.02k
Shares Outstanding 582.13M
Float 11.15M
% Held by Insiders 11.42%
% Held by Institutions 117.97%
Shares Short (Oct 31, 2018) 4430.05k
Short Ratio (Oct 31, 2018) 412.02
Short % of Float (Oct 31, 2018) 4N/A
Short % of Shares Outstanding (Oct 31, 2018) 42.61%
Shares Short (prior month Sep 28, 2018) 4449.67k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A